134 related articles for article (PubMed ID: 10553426)
1. [Breast cancer with osteoblastic bone metastasis treated successfully with bisphosphonate: a case report].
Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1651-5. PubMed ID: 10553426
[TBL] [Abstract][Full Text] [Related]
2. [Study on the safety of rapid infusion and the efficacy of incadronate against bone metastasis of breast cancer].
Oura S; Sakurai T; Yoshimura G; Tamaki T; Umemura T; Kokawa Y; Naito Y
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1623-8. PubMed ID: 10553421
[TBL] [Abstract][Full Text] [Related]
3. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases].
Sueyoshi K; Ogura Y; Komori T; Takahashi M; Tian TX; Tatsumi T; Matsuki M; Saika Y; Uesugi Y; Utsunomiya K; Inomata Y; Narabayashi I
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1795-9. PubMed ID: 12402432
[TBL] [Abstract][Full Text] [Related]
4. [A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].
Kokufu I; Taniguchi H; Kim YH; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
Gan To Kagaku Ryoho; 2000 Aug; 27(9):1425-8. PubMed ID: 10969600
[TBL] [Abstract][Full Text] [Related]
5. [A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].
Kubo N; Katayama K; Ishizaki A; Morinaga N; Negishi T; Kuwano H
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1973-5. PubMed ID: 19011355
[TBL] [Abstract][Full Text] [Related]
6. [A case of breast cancer with multiple bone metastases demonstrating complete remission with high-dose toremifene therapy].
Saito Y; Amano S; Kashio M; Abe H; Kuboi Y; Sakurai K; Aoki N; Hata S; Negishi N
Gan To Kagaku Ryoho; 2004 Jun; 31(6):911-4. PubMed ID: 15222111
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates and metastatic breast carcinoma.
Lipton A
Cancer; 2003 Feb; 97(3 Suppl):848-53. PubMed ID: 12548585
[TBL] [Abstract][Full Text] [Related]
8. [A case report of bone metastasis diagnosed by MRI and effectively treated with UFT after breast conserving therapy for breast cancer].
Nishioka A; Ogawa Y; Hamada N; Terashima M; Sawada A; Inomata T; Tanaka Y; Ogoshi S
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2251-4. PubMed ID: 1444493
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer: bisphosphonate therapy for metastatic bone disease.
Body JJ
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6258s-6263s. PubMed ID: 17062710
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and cost of bisphosphonate therapy in tumor bone disease.
Body JJ
Cancer; 2003 Feb; 97(3 Suppl):859-65. PubMed ID: 12548587
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
[TBL] [Abstract][Full Text] [Related]
15. [Pamidronate therapy for lung cancer patients with bone metastasis].
Oura S; Yoshimasu T; Sakurai T; Nakamura T; Kokawa Y; Matsuyama K; Ohta F; Naito Y
Gan To Kagaku Ryoho; 2000 Jul; 27(7):1057-60. PubMed ID: 10925695
[No Abstract] [Full Text] [Related]
16. Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study.
Hultborn R; Gundersen S; Ryden S; Holmberg E; Carstensen J; Wallgren UB; Killany S; Andreassen L; Carlsson G; Fahl N; Hatschek T; Sommer HH; Hessman Y; Hornmark-Stenstam B; Johnsborg S; Klepp R; Laino R; Niklasson LG; Rudenstam CM; Sundbeck A; Söderberg M; Tejler G
Anticancer Res; 1999; 19(4C):3383-92. PubMed ID: 10629624
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
18. Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma: a case report.
Osanai T; Tsuchiya T; Ogino T; Nakahara K
Gynecol Oncol; 2006 Jan; 100(1):195-7. PubMed ID: 16169581
[TBL] [Abstract][Full Text] [Related]
19. Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.
Vogel CL; Yanagihara RH; Wood AJ; Schnell FM; Henderson C; Kaplan BH; Purdy MH; Orlowski R; Decker JL; Lacerna L; Hohneker JA
Oncologist; 2004; 9(6):687-95. PubMed ID: 15561812
[TBL] [Abstract][Full Text] [Related]
20. [The analgesic effect of calcitonin on breast cancer patients with bone metastases].
Kimura M; Abe R
Gan No Rinsho; 1987 Jul; 33(8):921-7. PubMed ID: 3613114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
